This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Intracorporeal Versus Extracorporeal Anastomotic After Laparoscopic Right Colectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05493033
Recruitment Status : Not yet recruiting
First Posted : August 9, 2022
Last Update Posted : December 1, 2023
Information provided by (Responsible Party):
Zhongtao Zhang, Beijing Friendship Hospital

Brief Summary:

Background: Laparoscopic assisted right hemicolectomy is recommended for right colon cancer. As a more minimally invasive procedure, intracorporeal ileocolic anastomosis has potential advantages: reducing torsion and traction on the mesentery, reducing skin incision length and enhancing postoperative recovery. However, the longer operative time, greater risk of intra-abdominal infection and steep learning curve for intestinal anastomosis performed under laparoscopic conditions, does this increase the incidence of postoperative complications, especially the incidence of anastomotic leakage, and whether it affects There is no high-level research evidence on the survival of patients.

Study design: COlOR IV study is an international prospective, multicenter, randomized controlled clinical study of intraperitoneal anastomosis versus extraperitoneal anastomosis after laparoscopic right hemicolectomy for colon cancer . The study will include a quality assessment phase before randomisation to ensure required competency level and uniformity of the intracorporeal and extracoporeal techniques.

Endpoint: Primary outcome is anastomotic leakage within 30 days after surgery. Main secondary endpoint is 3-year disease-free survival rate. Secondary endpoints are mortality and morbidity, postoperative recovery, overall survival, surgical specimen quality, quality of life.

Statistics: The primary endpoint is anastomotic leakage within 30 days after surgery. The anastomotic leakage rate was set to 2% in the both groups, and an increase in the incidence of anastomotic leakage of 2.5% was considered inferior. The one-sided significance level was 0.025, the power was 0.9. The dropout rate was 20%, and taking into account the post-randomization analysis (dropout 5%), the total sample size was 1158. There were 579 cases in the intracorporeal anastomosis group and 579 cases in the extracorporeal anastomosis group.

Main selection: Patients with histologically proven right colon cancer (cecum, ascending colon and proximal 1/3 of the transverse colon malignant tumor), clinically stage I-III, and intention for right hemicolectomy with primary anastomosis.

Hypothesis: The hypothesis is that intracoporeal anastomosis will have comparable anastomotic leak rate and 3-year DFS, but faster postoperative recovery with extracoporeal anastomosis.

Condition or disease Intervention/treatment Phase
Colon Cancer Procedure: Intracorporeal anastomotic after LRC Procedure: Extracorporeal anastomotic after LRC Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1158 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Multicenter Randomized Clinical Trial Comparing Intracorporeal and Extracorporeal Ileocolic Anastomotic After Laparoscopic Right Colectomy for Colon Cancer (COLOR IV)
Estimated Study Start Date : December 1, 2023
Estimated Primary Completion Date : January 1, 2027
Estimated Study Completion Date : January 1, 2030

Arm Intervention/treatment
Experimental: Intracorporeal anastomotic after LRC Procedure: Intracorporeal anastomotic after LRC
Complete laparoscopic dissection of the mesocolon is mandatory. D2 or D3/CME is optional. And the extent of colon resection is based on the location of the tumor while the ileocecal resection is excluded. After fully mobilization of the colon and mesentery, the terminal ileum and transverse colon will be transected by a laparoscopic linear stapler. The side-to-side anastomosis is performed laparoscopically. The enterotomy is closed by a double-layer suture. All the anastomotic procedures are completed laparoscopically. The specimen is then removed through a Pfannenstiel incision within a specimen bag.

Active Comparator: Extracorporeal anastomotic after LRC Procedure: Extracorporeal anastomotic after LRC
The procedures of the mobilization and vessel ligation are similar. After that, the mobilized colon and terminal ileum are brought out through the upper mid-line incision with the wound protector. The colon and terminal ileum are similarly dissected distally to the specimen with a stapling device. The side-to-side anastomosis is completed and the anastomotic site is reinforced. The anastomotic bowel is returned to the abdominal cavity.

Primary Outcome Measures :
  1. Anastomotic leak [ Time Frame: 30 days ]

    Anastomotic leakage is defined as a defect of the intestinal wall at the anastomotic site leading to a communication between intra- and extraluminal compartments.

    Diagnosis of anastomotic leakage: The radiological examination (CT abdomen) will be completed if clinically suspected AL. AL is confirmed clinically, radiologically, endoscopically or intraoperatively. The severity of anastomotic leakage was judged with reference to the Clavien-Dindo classification.

Secondary Outcome Measures :
  1. Disease-free survival rate [ Time Frame: 3/5 years ]
    Main secondary outcome

  2. Overall survival [ Time Frame: 3/5 years ]
  3. morbidity [ Time Frame: 5 years ]
  4. Mortality [ Time Frame: 5 years ]
  5. Duration of surgery [ Time Frame: Intraoperative ]
    from incision to suture completion

  6. Duration of anastomosis [ Time Frame: Intraoperative ]
    from the start of dissection of the bowel to the compeletion of the anastomosis

  7. Surgical incision length [ Time Frame: Intraoperative ]
  8. Conversion rate [ Time Frame: 1 month ]
    conversion to open surgery or conversion to extracorporeal anastomosis

  9. Pain score (VAS score) [ Time Frame: 1-3 days ]
    The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Ask the patient to rate their current level of pain by placing a mark on the line.

  10. Time to first flatus passage after surgery [ Time Frame: 1 month ]
    The day of surgery is day 0. The time interval between the day of the first flatus passage after surgery and the day of surgery.

  11. Time to first stool passage after surgery [ Time Frame: up to 1 week ]
    The day of surgery is day 0. The time interval between the day of the first stool passage after surgery and the day of surgery.

  12. Time to first oral intake [ Time Frame: up to 1 week ]
    The day of surgery is day 0. The time interval between the day of the first oral intake after surgery and the day of surgery.

  13. Length of hospital stay after surgery [ Time Frame: 1 month ]
    days from surgery to discharge

  14. Specimen quality [ Time Frame: 1 month ]

    West pathological assessment criteria. Grading of the plane of mesocolic dissection.

    1. Muscularis propria plane:little bulk to mesocolon with disruptions extending down onto the muscularis propriapropria
    2. Intramesocolic plane: moderate bulk to mesocolon with irregularity but the incisions do not reach down to the muscularis propria
    3. Mesocolic plane: intact mesocolon with a smooth peritoneal-lined surface

  15. Health-related quality of life [ Time Frame: 1 year ]
    EORTC QLQ-CR29 and C30: questionnaires to evaluate the overall quality of life of patients with colorectal cancer, including 30 and 29 items, respectively, to score patients' overall quality of life, function, and symptoms. These are coded with four-point scales, namely "Not at all", "A little", "Quite a bit" and "Very much."

  16. health-related quality of life [ Time Frame: 1 year ]
    EQ 5D-5L (Euroqol): This questionnaire is a simple, generic tool for describing and assessing health-related quality of life. It consists of 5 items (mobility, personal care, activities of daily living, pain and anxiety and depression) that answer questions on a 5-point scale ranging from "no problem" (level 1) to "very severe" (level 5).

  17. Incision herniation [ Time Frame: 1 year ]
    The incision herniation is classified by the criteria of the European Hernia Society. The location (Midline/Lateral) and size (length and width) of the herniation will be recorded.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion criteria

  1. Age: 18 ~ 80 years, male or female;
  2. Histological or cytological diagnosis of right colon cancer (cecum, ascending colon and proximal 1/3 of the transverse colon cancer);
  3. Stage I-III according to the AJCC-TNM classification including downstaged tumor based on adequate imaging of the thorax and abdomen;
  4. Intention for right hemicolectomy (including extended right hemicolectomy) with primary anastomosis;
  5. Informed consent according to local requirements Exclusion criteria

1) T4b tumor determined by CT scan; 2) Malignancy other than adenocarcinoma at histological examination ; 3)Other malignancies in medical history, except adequately treated basocellular carcinoma of the skin or in situ carcinoma of the cervix uteri; 4) Previous history of colorectal cancer or synchronous multiple colorectal malignancies; 5) Complications requiring emergency surgery (obstruction, perforation, etc); 6) Planned synchronous abdominal organ resections; 7) Pregnant or lactating women; 8) Familial Adenomatosis Polyposis Coli (FAP), active Crohn's disease or active ulcerative colitis; 9) Absolute contraindication to general anesthesia or laparoscopic surgery.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT05493033

Layout table for location contacts
Contact: Hongwei Yao, Prof +8613611015609

Sponsors and Collaborators
Beijing Friendship Hospital
Layout table for investigator information
Principal Investigator: Zhongtao Zhang, Prof Department of General Surgery, Beijing Friendship Hospital, Capital Medical University
Principal Investigator: Hendrik J Bonjer, Prof Amsterdam UMC, location VUmc
Study Director: Hongwei Yao, Prof Department of General Surgery, Beijing Friendship Hospital, Capital Medical University
Layout table for additonal information
Responsible Party: Zhongtao Zhang, professor, Beijing Friendship Hospital Identifier: NCT05493033    
Other Study ID Numbers: COLOR IV Trial
First Posted: August 9, 2022    Key Record Dates
Last Update Posted: December 1, 2023
Last Verified: November 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: We are not sharing confidential individual patient data.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Zhongtao Zhang, Beijing Friendship Hospital:
intracorporeal anastomosis
anastomotic leak
Additional relevant MeSH terms:
Layout table for MeSH terms
Colonic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases